share_log

石藥集團：董事會召開日期

CSPC PHARMA: DATE OF BOARD MEETING

香港交易所 ·  Mar 8 04:39
Summary by Moomoo AI
石藥集團有限公司（「石藥集團」）宣布，將於2024年3月20日（星期三）召開董事會會議，主要議程為批准截至2023年12月31日止年度的全年業績，以及考慮是否派發末期股息。會議由董事長蔡東晨先生主持，並於2024年3月8日向香港交易及結算所有限公司及香港聯合交易所有限公司發出通知。董事會成員包括執行董事和獨立非執行董事，共計十二位成員。
石藥集團有限公司（「石藥集團」）宣布，將於2024年3月20日（星期三）召開董事會會議，主要議程為批准截至2023年12月31日止年度的全年業績，以及考慮是否派發末期股息。會議由董事長蔡東晨先生主持，並於2024年3月8日向香港交易及結算所有限公司及香港聯合交易所有限公司發出通知。董事會成員包括執行董事和獨立非執行董事，共計十二位成員。
Petropharmacy Group Limited (the “Petropharmacy Group”) announces that a Board Meeting will be held on Wednesday, March 20, 2024, with the main agenda being the approval of the annual results for the year ended December 31, 2023, and consideration of the distribution of a final dividend. The meeting was chaired by Mr. Tung Chen, Chairman, and notified to Hong Kong Trading and Settlement Limited and Hong Kong Stock Exchange Limited on 8 March 2024. The members of the Board of Directors consist of executive directors and independent non-executive directors with a total of twelve members.
Petropharmacy Group Limited (the “Petropharmacy Group”) announces that a Board Meeting will be held on Wednesday, March 20, 2024, with the main agenda being the approval of the annual results for the year ended December 31, 2023, and consideration of the distribution of a final dividend. The meeting was chaired by Mr. Tung Chen, Chairman, and notified to Hong Kong Trading and Settlement Limited and Hong Kong Stock Exchange Limited on 8 March 2024. The members of the Board of Directors consist of executive directors and independent non-executive directors with a total of twelve members.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more